Daily briefing: SGX hopes to attract IPO after new SPAC rules; SG tightens COVID measures for travelers

And Singapore donates 100,000 Pfizer doses to Johor.

From CNBC

The Singapore Exchange (SGX) is hopeful that the new rules on the listing of Special Purpose Acquisition Companies (SPAC) will attract more firms to launch their initial public offering in Singapore.

SGX Head of Equity Capital Markets Mohamed Nasser Ismail told CNBC that new technology companies in the region will see the SPACs in Singapore to be “attractive, valuable and sustainable.”

The new SPAC framework provided a minimum market capitalisation of S$150m.

Read more here.

From Bloomberg

Singapore imposed stricter pre-departure measures for travellers entering Singapore, starting 9 September, the Ministry of Health reported.

Travellers coming from high-risk areas will be required to present a negative pre-departure COVID-19 test within 48 hours before departing.

The government had previously allowed a 72-hour duration for pre-departure COVID-19 tests.

Read more here.

From Mothership

Singapore will be donating some 100,000 doses of Pfizer-BioNTech vaccine for COVID-19 to the State of Johor, its Chief Minister Hasni Mohammad said.

According to Johor Chief Minister Hasni the new round of vaccine is on top of the 20,000 doses of Sinovac vaccine Singapore sent last 29 July.

Johor had also previously received 300,000 doses of SinoPharm from the UAE.

Read more here.

Join Singapore Business Review community

Follow the link s for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.